Foundayo: The UK’s newest weight loss pill set to be ‘much cheaper’ than jabs

It could work out a fair whack cheaper, but results aren’t quite as dramatic as jabs (Picture: Getty Images)

There’s a new kid on the block when it comes to weight loss treatments — and it’s set to give jabs a run for their money.

This week, the UK became the first country in Europe to approve the use of orforglipron — branded as Foundayo — for weight management and type 2 diabetes.

Made by Mounjaro manufacturer Eli Lilly, it’s one of two GLP-1 pills to receive Medicines and Healthcare produ...